Works matching IS 0008543X AND DT 2007 AND VI 109 AND IP 5


Results: 24
    1
    2
    3
    4
    5
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Phase II study of low‐dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemiaPresented in part at the 47th Annual Meeting of the American Society of Hematology, Atlanta, GA, December 10–13, 2005

    Published in:
    Cancer (0008543X), 2007, v. 109, n. 5, p. 899, doi. 10.1002/cncr.22470
    By:
    • Yasuhiro Oki;
    • Hagop M. Kantarjian;
    • Vazganush Gharibyan;
    • Dan Jones;
    • Susan O'Brien;
    • Srdan Verstovsek;
    • Jorge Cortes;
    • Gail M. Morris;
    • Guillermo Garcia‐Manero;
    • Jean‐Pierre J. Issa
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24